Recombinant GLP1R (Dulaglutide Biosimilar) antibody

Catalog No. ABIN7538050

The Human Monoclonal anti-GLP1R (Dulaglutide Biosimilar) antibody (ABIN7538050) specifically detects GLP1R (Dulaglutide Biosimilar) in ELISA and WB. The antibody is reactive with Human samples.

Quick Overview for Recombinant GLP1R (Dulaglutide Biosimilar) antibody (ABIN7538050)

Target: GLP1R (Dulaglutide Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-GLP1R (Dulaglutide Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Dulaglutide Biosimilar - Anti-Glucagon-like peptide-1 receptor agonist mAb - Research Grade

Characteristics: Antibody Type: hG4-Fc

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG4

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: 4 °C,-20 °C

Storage Comment: 4°C for short term, -20°C for long term

Target Details for GLP1R (Dulaglutide Biosimilar)

Target: GLP1R (Dulaglutide Biosimilar)

Target Type: Biosimilar

Background: Dulaglutide is a novel glucagon-like peptide-1 agonist (GLP-1) biologic drug consisting of a dipeptidyl peptidase-IV-protected GLP-1 analogue covalently linked to a human IgG4-Fc heavy chain by a small peptide linker. Dulaglutide is indicated in the treatment of type 2 diabetes and can be used once a week.

Molecular Weight: 59 kDa

CAS-No: 923950-08-7